Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Will ‘Game Changer’ Antipsychotic Live Up to the Hype?
The US Food and Drug Administration (FDA) is due to issue a decision by September 26 on the approval of KarXT, a potential first-in-class antipsychotic. If approved, it would be the first drug with a novel mechanism to treat schizophrenia…
English